Vipivotide tetraxetan Ligand-Linker Conjugate
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-43869-5MG | 5 mg | 406,00 | Add | |
| HY-43869-10MG | 10 mg | 647,00 | Add | |
| HY-43869-50MG | 50 mg | 1'914,00 | Add | |
| HY-43869-100MG | 100 mg | 2'927,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Vipivotide tetraxetan Ligand-Linker Conjugate (PSMA-617 Ligand-Linker Conjugate) is a complex composed of pharmacophore group Glutamate-urea-Lysine peptide coupling linker, which can be used to synthesize Vipivotide tetraxetan (PSMA-617). Glutamate-urea-Lysine selectively binds to prostate-specific membrane antigen (PSMA)[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Antibody-drug Conjugate/ADC Related |
| Format | Solubility: DMSO : 125 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.95% |
| Molecular Formula | C33H45N5O9 |
| Molecular Weight | 655.74 |
| CAS-Number | 1703768-74-4 |
| Storage Conditions | -20°C, 3 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
